Peter B. Illei

16.2k citations

151 papers · 8.3k indexed · 2 hit papers · h-index 48

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
- Occupational and environmental lung diseases
- Lung Cancer Treatments and Mutations
- Sarcoma Diagnosis and Treatment
- Medical Imaging and Pathology Studies
Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research

Papers in

Pulmonary and Respiratory Medicine 84
- Lung Cancer Treatments and Mutations 25
- Lung Cancer Diagnosis and Treatment 15
- Occupational and environmental lung diseases 12
- Medical Imaging and Pathology Studies 11
Cancer Research 29
- Cancer Genomics and Diagnostics 18

Co-authors: Marc Ladanyi Rajni Sharma Pedram Argani Valerie W. Rusch George J. Netto Glyn Morgan Lewis Teperman Neil D. Theise
Journals: The American Journal of Surgical Pathology (20 papers)Human Pathology (14 papers)Journal of Clinical Oncology (8 papers)CHEST Journal (5 papers)Modern Pathology (4 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Peter B. Illei

146 papers receiving 8.1k citations

Hit Papers

align trajectories log scale

Assessment of Advanced Diagnostic Bronchoscopy Outcomes for Peripheral Lung Lesions: A Delphi Consensus Definition of Diagnostic Yield and Recommendations for Patient-centered Study Designs. An Official American Thoracic Society/American College of Chest Physicians Research Statement 2024 · 39 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 American Journal of Respiratory and Critical Care Medicine
2000 Hepatology

Peers

Countries citing papers authored by Peter B. Illei

Since Specialization

Citations

This map shows the geographic impact of Peter B. Illei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter B. Illei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter B. Illei more than expected).

Fields of papers citing papers by Peter B. Illei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter B. Illei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter B. Illei. The network helps show where Peter B. Illei may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter B. Illei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter B. Illei Line = papers co-authored together Peter B. Illei links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Assessment of Advanced Diagnostic Bronchoscopy Outcomes for Peripheral Lung Lesions: A Delphi Consensus Definition of Diagnostic Yield and Recommendations for Patient-centered Study Designs. An Official American Thoracic Society/American College of Chest Physicians Research Statement American Journal of Respiratory and Critical Care Medicine ·Anne V. Gonzalez, Gerard A. Silvestri, Daniël A. Korevaar, Yaron Gesthalter, N. Almeida, Alex Chen, Christopher R. Gilbert, Peter B. Illei, Neal Navani, Mary Pasquinelli, Nicholas J. Pastis, Catherine R. Sears, Samira Shojaee, Stephen B. Solomon, Daniel Steinfort, Fabien Maldonado, M. Patricia Rivera, Lonny Yarmus Hit paper breakdown →	2024	39
2	Acquisition and Handling of Endobronchial Ultrasound Transbronchial Needle Samples CHEST Journal ·Christopher R. Gilbert, Kyle B. Konold, A. Christine Argento, David Feller‐Kopman, Anne V. Gonzalez, Felix Herth, Jonathan M. Iaccarino, Peter B. Illei, Kevin O’Neil, Nicholas J. Pastis, HU De-ma, Lynette M. Sholl, Gerard A. Silvestri, Jeffrey Thiboutot, Momen M. Wahidi, 李治滢, Lonny Yarmus	2024	6
3	Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer Clinical Cancer Research ·Samuel Rosner, Joshua E. Reuss, Marianna Zahurak, Jiajia Zhang, Qiulin Dan, Janis M. Taube, Valsamo Anagnostou, Kellie N. Smith, Joanne Riemer, Peter B. Illei, Stephen Broderick, David R. Jones, Suzanne L. Topalian, Drew M. Pardoll, Julie R. Brahmer, Jamie E. Chaft, Patrick M. Forde	2023	44
4	Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study Journal for ImmunoTherapy of Cancer ·Khinh Ranh Voong, Peter B. Illei, Bob. Carter, Dipika Singh, Qiulin Dan, Mara Lanis, Russell K. Hales, Chen Hu, Phuoc T. Tran, Christos Georgiades, Cheng Ting Lin, Maria Francesca Fais, Julie R. Brahmer, Patrick M. Forde, Jarushka Naidoo, Valsamo Anagnostou, Kellie N. Smith	2023	4
5	Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)–part 2: subjective views among the cytopathology community Journal of the American Society of Cytopathology ·Jennifer L. Sauter, Erlan Fartawijaya, Deepu Alex, Ronald Balassanian, Shehab Ayman, Melina Flanagan, Christopher C. Griffith, Peter B. Illei, Daniel N. Johnson, Cindy McGrath, Melissa Randolph, Jordan Reynolds, Begzudin Ahmetovic, Annemieke van Zante, Paul A. VanderLaan	2020	10
6	Results from the 2019 American Society of Cytopathology survey on rapid on-site evaluation—Part 1: objective practice patterns Journal of the American Society of Cytopathology ·Paul A. VanderLaan, Erlan Fartawijaya, Deepu Alex, Ronald Balassanian, Shehab Ayman, Rana S. Hoda, Peter B. Illei, Cindy McGrath, Melissa Randolph, Jordan Reynolds, Begzudin Ahmetovic, P. Farrington, Annemieke van Zante, Jennifer L. Sauter	2019	34
7	RELMα Licenses Macrophages for Damage-Associated Molecular Pattern Activation to Instigate Pulmonary Vascular Remodeling The Journal of Immunology ·Qing Lin, Chunling Fan, John Skinner, Jonas Økern, A Macdonald, Peter B. Illei, Kazuyo Yamaji-Kegan, Roger A. Johns	2019	25
8	PUB047 SATB2 Expression in Lug Adenocarcinoma Journal of Thoracic Oncology ·Daniel L. Miller, Edward Gabrielson, Qing Kay Li, Peter B. Illei	2017	1
9	The utility of bronchial brushings in the modern era of flexible bronchoscopy Journal of the American Society of Cytopathology ·Christopher J. VandenBussche, Lonny Yarmus, Peter B. Illei	2016	0
10	Stylet Use Does Not Improve Diagnostic Outcomes in Endobronchial Ultrasonographic Transbronchial Needle Aspiration CHEST Journal ·Erik Scholten, Roy Semaan, Peter B. Illei, Christopher Mallow, Sixto Arias, David Feller‐Kopman, Maurício Balbinonotti Ferrari, M. A. Seabolt, Ricardo O. Amador, Hans C. Lee, Lonny Yarmus	2016	17
11	SPARC Expression Did Not Predict Efficacy of nab -Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial Clinical Cancer Research ·Manuel Hidalgo, Carlos Plaza, Mónica Musteanu, Peter B. Illei, Carrie Baker Brachmann, Carla Heise, D. T. Pierce, Pedro P. López‐Casas, Camino Menéndez, Josep Tabernero, Alfredo Romano, Xinyu Wei, Fernando López‐Ríos, Daniel D. Von Hoff	2015	102
12	NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas Journal of Clinical Pathology ·Jan Sondermann, Mark A. Samols, Mohammed Lilo, Andrea P. Subhawong, Rajni Sharma, Peter B. Illei, Pedram Argani, Ashley Cimino‐Mathews	2014	22
13	Sparc Analysis in the Phase III MPACT Trial of NAB-Paclitaxel (Nab-P) Plus Gemcitabine (GEM) vs GEM Alone for Patients with Metastatic Pancreatic Cancer (PC) Annals of Oncology ·Manuel Hidalgo, Carlos Plaza, Peter B. Illei, Carrie Baker Brachmann, Carla Heise, Daniel W. Pierce, Andrea Romano, Xinyu Wei, Fernando López‐Ríos, Daniel D. Von Hoff	2014	27
14	Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas Human Pathology ·Ashley Cimino‐Mathews, Andrea P. Subhawong, Hillary Elwood, Hind Nassar Warzecha, Rajni Sharma, Ben Ho Park, Janis M. Taube, Peter B. Illei, Pedram Argani	2012	122
15	Notch Signaling Contributes to Lung Cancer Clonogenic Capacity In Vitro but May Be Circumvented in Tumorigenesis In Vivo Molecular Cancer Research ·Fatuma Hassan, Irina Dobromilskaya, Peter B. Illei, Christine L. Hann, Charles M. Rudin	2011	32
16	A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma Annals of Surgery ·Naisui, Charles J. Yeo, Keith D. Lillemoe, Barbara Biedrzycki, Barry Kobrin, Joseph M. Herman, Elizabeth A. Sugar, Steven Piantadosi, John L. Cameron, Sara Solt, Beth Onners, Irena Tartakovsky, Miri Choi, Rajni Sharma, Peter B. Illei, Kim Hyejeong, Ross A. Abrams, Dung T. Le, Elizabeth M. Jaffee, Dan Laheru	2011	295
17	Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer PLoS ONE ·Lei Zheng, Kelly Foley, Lanqing Huang, Ashley Leubner, Guanglan Mo, Kelly Olino, Barish H. Edil, Masamichi Mizuma, Rajni Sharma, Dung T. Le, Robert A. Anders, Peter B. Illei, Jennifer E. Van Eyk, Anirban Maitra, Daniel A. Laheru, Elizabeth M. Jaffee	2011	156
18	Genitourinary Modern Pathology ·Marc Andriot, Monica Taylor, Peter B. Illei, Dilek Ertoy Baydar, Athanase Billis, Judith E. Epstein, George J. Netto	2010	2
19	Heterogeneity of Bcl-2 expression in metastatic breast carcinoma Modern Pathology ·Andrea P. Subhawong, Hind Nassar, Marc K. Halushka, Peter B. Illei, Russell Vang, Pedram Argani	2010	11
20	Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction Cancer Research ·Fernando López‐Ríos, Shannon Chuai, Raja M. Flores, Shigeki Shimizu, Takatoshi Ohno, Kazuhiko Wakahara, Peter B. Illei, Jaime Montoya Larrahondo, Lee M. Krug, Maureen F. Zakowski, Valerie W. Rusch, Adam B. Olshen, Marc Ladanyi	2006	193

About Peter B. Illei

Peter B. Illei is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Pathology and Forensic Medicine and Surgery, having authored 151 papers that have together received 8.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Cancer Genomics and Diagnostics (18 papers), Lung Cancer Diagnosis and Treatment (15 papers), Renal and related cancers (13 papers), Occupational and environmental lung diseases (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), Medical Imaging and Pathology Studies (11 papers) and Cancer Cells and Metastasis (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.9k citations), Oncology (2.7k citations), Cancer Research (1.4k citations), Hepatology (592 citations) and Otorhinolaryngology (271 citations). Peter B. Illei has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marc Ladanyi, Rajni Sharma, Pedram Argani, Valerie W. Rusch, George J. Netto, Glyn Morgan, Lewis Teperman, Neil D. Theise, Octavian Henegariu and Diane S. Krause. Their work appears in journals such as The American Journal of Surgical Pathology, Human Pathology, Journal of Clinical Oncology, CHEST Journal and Modern Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact